Publications by authors named "Shingo Eikawa"

Claim this Profile
A
Antitumor immunity as the basis for durable disease-free treatment-free survival in patients with metastatic urothelial cancer.
Jonathan Anker, Sumanta K Pal, Seunghee Kim-Schulze, Huan Wang, Rebecca Halperin, Shingo Eikawa

J Immunother Cancer· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor-resident regulatory T cells in pancreatic cancer express the αvβ5 integrin as a targetable activation marker.
Kodai Suzuki, Yuki Kunisada, Norio Miyamura, Shingo Eikawa, Tatiana Hurtado de Mendoza

bioRxiv· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dysfunction of CD8 + PD-1 + T cells in type 2 diabetes caused by the impairment of metabolism-immune axis.
Ichiro Nojima, Shingo Eikawa, Nahoko Tomonobu, Yoshiko Hada, Nobuo Kajitani

Sci Rep· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Berberine improved experimental chronic colitis by regulating interferon-γ- and IL-17A-producing lamina propria CD4 T cells through AMPK activation.
Masahiro Takahara, Akinobu Takaki, Sakiko Hiraoka, Takuya Adachi, Yasuyuki Shimomura, Shingo Eikawa

Sci Rep· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metformin induces CD11b+-cell-mediated growth inhibition of an osteosarcoma: implications for metabolic reprogramming of myeloid cells and anti-tumor effects.
Takenori Uehara, Shingo Eikawa, Mikako Nishida, Yuki Kunisada, Aki Yoshida

Int Immunol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Attenuation of CD4CD25 Regulatory T Cells in the Tumor Microenvironment by Metformin, a Type 2 Diabetes Drug.
Yuki Kunisada, Shingo Eikawa, Nahoko Tomonobu, Shohei Domae, Takenori Uehara

EBioMedicine· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Metabolic Competition in Tumor Microenvironment].
Shingo Eikawa, Heiichiro Udono

Gan To Kagaku Ryoho· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Metformin-dependent metabolic reprogramming contributes to efficient anti-tumor immunity].
Nahoko Tomonobu, Shingo Eikawa, Heiichiro Udono

Nihon Rinsho· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AntiTumor and Immunoregulatory Effects of Fermented Papaya Preparation (FPP: SAIDOPS501).
Shinki Murakami, Shingo Eikawa, Savas Kaya, Mitsuko Imao, Toshiki Aji

Asian Pac J Cancer Prev· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Study about the Efficacy of Metformin to Immune Function in Cancer Patients.
Mototsugu Watanabe, Hiromasa Yamamoto, Shingo Eikawa, Kazuhiko Shien, Tadahiko Shien

Acta Med Okayama· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection and Tracking of NY-ESO-1-Specific CD8+ T Cells by High-Throughput T Cell Receptor β (TCRB) Gene Rearrangements Sequencing in a Peptide-Vaccinated Patient.
Manami Miyai, Shingo Eikawa, Akihiro Hosoi, Tamaki Iino, Hirokazu Matsushita

PLoS One· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune-mediated antitumor effect by type 2 diabetes drug, metformin.
Shingo Eikawa, Mikako Nishida, Shusaku Mizukami, Chihiro Yamazaki, Eiichi Nakayama

Proc Natl Acad Sci U S A· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increase in activated Treg in TIL in lung cancer and in vitro depletion of Treg by ADCC using an antihuman CCR4 mAb (KM2760).
Koji Kurose, Yoshihiro Ohue, Eiichi Sato, Akira Yamauchi, Shingo Eikawa

J Thorac Oncol· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monitoring multifunctionality of immune-exhausted CD8 T cells in cancer patients.
Shingo Eikawa, Shusaku Mizukami, Heiichiro Udono

Methods Mol Biol· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccination with NY-ESO-1 overlapping peptides mixed with Picibanil OK-432 and montanide ISA-51 in patients with cancers expressing the NY-ESO-1 antigen.
Hisashi Wada, Midori Isobe, Kazuhiro Kakimi, Yu Mizote, Shingo Eikawa

J Immunother· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Regulation of T-cell immune exhaustion and cancer immunotherapy].
Shingo Eikawa, Heiichiro Udono

Gan To Kagaku Ryoho· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction of CD8 T-cell responses restricted to multiple HLA class I alleles in a cancer patient by immunization with a 20-mer NY-ESO-1f (NY-ESO-1 91-110) peptide.
Shingo Eikawa, Kazuhiro Kakimi, Midori Isobe, Kiyotaka Kuzushima, Immanuel Luescher

Int J Cancer· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HSP70 and HSP90 Differentially Regulate Translocation of Extracellular Antigen to the Cytosol for Cross-Presentation.
Yu Kato, Chiaki Kajiwara, Ikuo Ishige, Shusaku Mizukami, Chihiro Yamazaki, Shingo Eikawa

Autoimmune Dis· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spontaneous antibody, and CD4 and CD8 T-cell responses against XAGE-1b (GAGED2a) in non-small cell lung cancer patients.
Yoshihiro Ohue, Shingo Eikawa, Nami Okazaki, Yu Mizote, Midori Isobe

Int J Cancer· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enrichment of Foxp3+ CD4 regulatory T cells in migrated T cells to IL-6- and IL-8-expressing tumors through predominant induction of CXCR1 by IL-6.
Shingo Eikawa, Yoshihiro Ohue, Kenta Kitaoka, Toshiki Aji, Akiko Uenaka

J Immunol· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation of high and decreased NY-ESO-1 immunity to spontaneous regression and subsequent recurrence in a lung cancer patient.
Midori Isobe, Shingo Eikawa, Akiko Uenaka, Yoichi Nakamura, Tetsuo Kanda

Cancer Immun· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis